Current News

Contact | Print version | PDF version | Send article | RSS feed

caprotec bioanalytics and Merck KGaA Sign Collaboration Agreement

30 May 2008 - caprotec bioanalytics GmbH announced that they have signed a collaboration agreement with Merck KGaA acting for its division Merck Serono. Under the terms of the agreement caprotec will apply its Capture Compound Mass Spectrometry(TM) (CCMS) Technology to identify relevant protein - drug molecule interactions for one of Merck Serono's research projects. caprotec will receive research funding and potential milestone payments on product development. Further financial details of the agreement were not disclosed.
 
"The collaboration with Merck Serono is an important milestone for caprotec. Merck Serono is a leader and innovator in the field, and this collaboration validates our capabilities for the development of improved small molecules." says caprotec's COO Mathias Grote. "Being able to collaborate with such an established player in this field provides an important further endorsement of our technology in the pharmaceutical industry".